These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 5659816)

  • 21. Electrical membrane activity and frequency-force relations in normal, denervated and reserpine-pretreated cat heart muscle.
    Spilker B; Cervoni P
    J Pharmacol Exp Ther; 1969 Jul; 168(1):60-9. PubMed ID: 5792686
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of the sympathomimetic action of cyclohexylamine and hexylamine: release of catecholamines from nerve endings.
    Wechsler AS; Epstein SE; Glick G
    J Pharmacol Exp Ther; 1969 Nov; 170(1):62-71. PubMed ID: 5351007
    [No Abstract]   [Full Text] [Related]  

  • 23. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure.
    Nobel-Allen N; Kirsch M; Lucchesi BR
    J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of cesium on the properties of cardiac muscle.
    Prasad K; Midha KK
    Jpn Heart J; 1973 Sep; 14(5):454-66. PubMed ID: 4543467
    [No Abstract]   [Full Text] [Related]  

  • 25. Catecholamine stores and the negative inotropic effect of beta-adrenergic blocking drugs on the isolated rabbit heart.
    Levy JV
    Arch Int Physiol Biochim; 1967 Jun; 75(3):381-404. PubMed ID: 4167703
    [No Abstract]   [Full Text] [Related]  

  • 26. Hemodynamic responses to beta-adrenergic blockade in dogs.
    Shen Y; Quiroz AC; Burch GE; DePasquale NP
    Am Heart J; 1967 May; 73(5):669-73. PubMed ID: 4225818
    [No Abstract]   [Full Text] [Related]  

  • 27. Selective blockade of adrenoceptive beta receptors in the heart.
    Dunlop D; Shanks RG
    Br J Pharmacol Chemother; 1968 Jan; 32(1):201-18. PubMed ID: 4384337
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues.
    Van Nueten JM; Janssen PA
    Arch Int Pharmacodyn Ther; 1973 Jul; 204(1):37-55. PubMed ID: 4746630
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of the inotropic action of glucagon by small concentration of angiotensin.
    Inoue K; Smulyan H; Mucha E; Eich RH
    Jpn Heart J; 1973 May; 14(3):239-48. PubMed ID: 4353886
    [No Abstract]   [Full Text] [Related]  

  • 30. Relaxing effects of catecholamines on mammalian heart.
    Morad M; Rolett EL
    J Physiol; 1972 Aug; 224(3):537-58. PubMed ID: 5071929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of vanadate on myocardial force of contraction.
    Scholz H; Hackbarth I; Schmitz W; Wetzel E
    Basic Res Cardiol; 1980; 75(3):418-22. PubMed ID: 6905762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of propranolol on the peripheral vascular bed.
    Nakano J; Kusakari T
    Nature; 1966 Feb; 209(5026):923-4. PubMed ID: 5922798
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta-receptor blockade and myocardial effects of cardiac glycosides.
    Koch-Weser J
    Circ Res; 1971 Feb; 28(2):109-18. PubMed ID: 4396194
    [No Abstract]   [Full Text] [Related]  

  • 34. Direct actions of prostaglandins E1, A1, F2 on myocardial contraction.
    Nutter DO; Ratts T
    Prostaglandins; 1973 Mar; 3(3):323-36. PubMed ID: 4729576
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of caffeine and other methylxanthines on mechanical properties of isolated mammalian heart muscle. Evidence for a dual mechanism of action.
    Blinks JR; Olson CB; Jewell BR; Bravený P
    Circ Res; 1972 Apr; 30(4):367-92. PubMed ID: 4401230
    [No Abstract]   [Full Text] [Related]  

  • 36. Adrenergic receptors in heart muscle: relations among factors influencing the sensitivity of the cat papillary muscle to catecholamines.
    Kaumann AJ
    J Pharmacol Exp Ther; 1970 Jun; 173(2):383-98. PubMed ID: 5434021
    [No Abstract]   [Full Text] [Related]  

  • 37. The cardiovascular pharmacology of ICI 170777 ((6RS)-6-methyl-5-(pyrid-4-yl)-3H,6H-1,3,4- thiadiazin-2-one) a novel compound with positive inotropic and vasodilator effects.
    Collis MG; Keddie JR; Rouse W
    Br J Pharmacol; 1989 Jun; 97(2):409-18. PubMed ID: 2758224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenyl cyclase and myocardial contractility.
    Epstein SE; Skelton CL; Levey GS; Entman M
    Ann Intern Med; 1970 Apr; 72(4):561-78. PubMed ID: 4315392
    [No Abstract]   [Full Text] [Related]  

  • 39. The actions of a new beta-adrenoceptor blocking drug, ICI 66082, on the rabbit papillary muscle and on the dog heart.
    Harry JD; Knapp MF; Linden RJ
    Br J Pharmacol; 1974 Jun; 51(2):169-77. PubMed ID: 4155970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cardiovascular effects of glucagon].
    Lavarenne J
    Therapie; 1974; 29(2):161-84. PubMed ID: 4368071
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.